Switch to:
Synageva BioPharma Corp (NAS:GEVA)
Earnings per share without Non-Recurring Items (NRI)
$-5.14 (TTM As of Sep. 2014)

Synageva BioPharma Corp's earnings per share without non-recurring items for the three months ended in Sep. 2014 was $-1.46. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Sep. 2014 was $-5.14.

During the past 3 years, the average earnings per share (NRI) Growth Rate was -78.50% per year.

GEVA' s 10-Year Earnings per share without Non-Recurring Items Growth(%) Range
Min: -78.5   Max: 30.5
Current: -78.5

-78.5
30.5

During the past 13 years, Synageva BioPharma Corp's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 30.50% per year. The lowest was -78.50% per year. And the median was 6.50% per year.

GEVA's Earnings per share without Non-Recurring Items Growth(%)is ranked higher than
50% of the 723 Companies
in the Global Biotechnology industry.

( Industry Median: -7.40 vs. GEVA: -78.50 )

Synageva BioPharma Corp's diluted earnings per share (Diluted EPS) for the three months ended in Sep. 2014 was $-1.46. Its diluted earnings per share (Diluted EPS) for the trailing twelve months (TTM) ended in Sep. 2014 was $-5.14.

Synageva BioPharma Corp's basic earnings per share (Basic EPS) for the three months ended in Sep. 2014 was $-1.46. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Sep. 2014 was $-5.14.


Definition

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company’s stock. In calculating earnings per share without non-recurring items, the dividends of preferred stocks and non-recurring items need to subtracted from the total net income first.

Synageva BioPharma Corp Earnings per share without Non-Recurring Items for the trailing twelve months (TTM) ended in Sep. 2014 was -1 (Dec. 2013 ) + -1.16 (Mar. 2014 ) + -1.52 (Jun. 2014 ) + -1.46 (Sep. 2014 ) = $-5.14

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

A non-recurring item refers to an entry that appears on a company's financial statements that is unlikely to happen again. It represents a one-time expense involving an unpredictable event and is not part of a firm's normal, day-to-day operations.


Be Aware

Compared with Earnings per share, a company’s cash flow is better indicator of the company’s earnings power.

If a company’s earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Related Terms

Non-Recurring Items, Diluted Earnings Per Share (Diluted EPS), Basic Earnings Per Share (Basic EPS)


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Synageva BioPharma Corp Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
eps_nri -9.30-1.851.656.201.802.76-343.10-8.58-1.90-3.40

Synageva BioPharma Corp Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
eps_nri -0.48-0.43-0.62-0.54-0.81-1.02-1.00-1.16-1.52-1.46
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK